Stock 7459 MEDIPAL HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases MediPal Holdings Corporation

Equities

7459

JP3268950007

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
2,468 JPY +2.26% Intraday chart for MediPal Holdings Corporation +4.53% +7.96%
2023 Tranche Update on MediPal Holdings Corporation's Equity Buyback Plan announced on May 12, 2023. CI
2023 MediPal Holdings Corporation's Equity Buyback announced on May 12, 2023 has closed with 4,171,900 shares, representing 1.97% for ¥9,999.86 million. CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MediPal : Notice of Basic Agreement concerning Integration between Consolidated Subsidiaries
PU
MediPal : Notice Regarding Progress of Acquisition of Treasury Stock
PU
Sumitomo Pharma Announces Completion of Share Transfer of Consolidated Subsidiary, Sumitomo Pharma Food and Chemical
AQ
Sumitomo Pharma Announces Transfer of Shares of a Consolidated Subsidiary, Sumitomo Pharma Food & Chemical
AQ
MediPal : Integrated Report 2020
PU
Cryoport : MEDIPAL HOLDINGS Partners with CRYOPORT to Bring Temperature-Controlled Supply Chain Solutions to the Japanese Market
AQ
Medipal : Notice of Revision of Year-End Dividend Forecast
PU
Medipal : JCR and MEDIPAL to Establish Joint Venture Company in U.S.
PU
MEDIPAL : and JCR Pharmaceuticals Co., Ltd. Strengthen Business and Capital Alliance
PU
Medipal : Summary of Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2018
PU
Medipal : Notice of Amounts of Assets and Liabilities Transferred from Consolidated Subsidiary through Absorption-type Demerger and Extraordinary Gain in Non-Consolidated Results
PU
Medipal : Notice of Revision of Year-End Dividend Forecast
PU
Medipal : Notice of Transfer of Subsidiary Business by Demerger (Simple Absorption-type Demerger)
PU
Medipal : Summary of Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2017
PU
Medipal : Notice of Differences between Forecast of Financial Results and Actual Results for the Interim Period of the Fiscal Year Ending March 31, 2017, Revisions to Forecast of Financial Results for the Fiscal Year Ending March 31, 2017, and Dividends and Revisions to Dividend Forecast (Dividend Increase) at Consolidated Subsidiary PALTAC CORPORATION
PU
Medipal : Notice of Revision to Full-Year Results Forecast
PU
Medipal : Summary of Consolidated Financial Statements for the Interim Period of the Fiscal Year Ending March 31, 2017
PU
Medipal : Summary of Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2017
PU
MEDIPAL : Announces Its New Medium-Term Vision
PU
Medipal : JCR and MEDIPAL Announce Signing of Agreement on Pharmaceutical Development Investment
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 7459 Stock
  4. News MediPal Holdings Corporation
  5. Press Releases